AstraZeneca Plans to Launch 100 New Medicines in China by 2029
AstraZeneca’s EVP Sharon Barr reveals the company’s plans to launch 100 new medicines in China over the next five years, highlighting mutual interests with Chinese collaborators.
PharmaInnovation
Read More
China Leverages Quantum Computing to Boost Drug Development
Bengbu Medical University partners with Origin Quantum to utilize quantum computing in enhancing small molecule drug development, boosting speed and precision in drug design.
AstraZeneca Boosts Presence in the Chinese Mainland with Major Pharma Investments
AstraZeneca CEO Pascal Soriot discusses the company’s strategic investments in the Chinese mainland’s pharmaceutical sector during an interview with CGTN’s Zheng Junfeng.
Cuba’s Homegrown COVID-19 Vaccines Enter Critical Trial Phase
Cuba leverages decades of vaccine expertise to develop four COVID-19 candidates, positioning itself as a key player in global pandemic response efforts.